Medical Care
Global Sterile Intravenous (IV) Solution Market Research Report 2025
- Sep 18, 25
- ID: 506941
- Pages: 81
- Figures: 85
- Views: 12
This report aims to provide a comprehensive presentation of the global market for Sterile Intravenous (IV) Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Intravenous (IV) Solution.
The Sterile Intravenous (IV) Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sterile Intravenous (IV) Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sterile Intravenous (IV) Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun Medical Inc.
Technoflex
Baxter International
ICU Medical, Inc
Mckesson
Amsino
Wallcur
Hebei Guangren Pharmaceutical Technology
Jiangsu Hengfengqiang Biotechnology
Hospira
Jiangsu Hengfengqiang Biotechnology
Hospira
Xi'an Libang Alliance Enterprise Management
Livzon Group
Segment by Type
Crystalloids
Colloids
Others
Segment by Application
Medications
NutritionNutrition
Blood-based Products
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sterile Intravenous (IV) Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Sterile Intravenous (IV) Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sterile Intravenous (IV) Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sterile Intravenous (IV) Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
B. Braun Medical Inc.
Technoflex
Baxter International
ICU Medical, Inc
Mckesson
Amsino
Wallcur
Hebei Guangren Pharmaceutical Technology
Jiangsu Hengfengqiang Biotechnology
Hospira
Jiangsu Hengfengqiang Biotechnology
Hospira
Xi'an Libang Alliance Enterprise Management
Livzon Group
Segment by Type
Crystalloids
Colloids
Others
Segment by Application
Medications
NutritionNutrition
Blood-based Products
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sterile Intravenous (IV) Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Crystalloids
1.2.3 Colloids
1.2.4 Others
1.3 Market by Application
1.3.1 Global Sterile Intravenous (IV) Solution Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medications
1.3.3 NutritionNutrition
1.3.4 Blood-based Products
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sterile Intravenous (IV) Solution Market Perspective (2020-2031)
2.2 Global Sterile Intravenous (IV) Solution Growth Trends by Region
2.2.1 Global Sterile Intravenous (IV) Solution Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sterile Intravenous (IV) Solution Historic Market Size by Region (2020-2025)
2.2.3 Sterile Intravenous (IV) Solution Forecasted Market Size by Region (2026-2031)
2.3 Sterile Intravenous (IV) Solution Market Dynamics
2.3.1 Sterile Intravenous (IV) Solution Industry Trends
2.3.2 Sterile Intravenous (IV) Solution Market Drivers
2.3.3 Sterile Intravenous (IV) Solution Market Challenges
2.3.4 Sterile Intravenous (IV) Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sterile Intravenous (IV) Solution Players by Revenue
3.1.1 Global Top Sterile Intravenous (IV) Solution Players by Revenue (2020-2025)
3.1.2 Global Sterile Intravenous (IV) Solution Revenue Market Share by Players (2020-2025)
3.2 Global Sterile Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sterile Intravenous (IV) Solution Revenue
3.4 Global Sterile Intravenous (IV) Solution Market Concentration Ratio
3.4.1 Global Sterile Intravenous (IV) Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sterile Intravenous (IV) Solution Revenue in 2024
3.5 Global Key Players of Sterile Intravenous (IV) Solution Head office and Area Served
3.6 Global Key Players of Sterile Intravenous (IV) Solution, Product and Application
3.7 Global Key Players of Sterile Intravenous (IV) Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sterile Intravenous (IV) Solution Breakdown Data by Type
4.1 Global Sterile Intravenous (IV) Solution Historic Market Size by Type (2020-2025)
4.2 Global Sterile Intravenous (IV) Solution Forecasted Market Size by Type (2026-2031)
5 Sterile Intravenous (IV) Solution Breakdown Data by Application
5.1 Global Sterile Intravenous (IV) Solution Historic Market Size by Application (2020-2025)
5.2 Global Sterile Intravenous (IV) Solution Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sterile Intravenous (IV) Solution Market Size (2020-2031)
6.2 North America Sterile Intravenous (IV) Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sterile Intravenous (IV) Solution Market Size by Country (2020-2025)
6.4 North America Sterile Intravenous (IV) Solution Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sterile Intravenous (IV) Solution Market Size (2020-2031)
7.2 Europe Sterile Intravenous (IV) Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sterile Intravenous (IV) Solution Market Size by Country (2020-2025)
7.4 Europe Sterile Intravenous (IV) Solution Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sterile Intravenous (IV) Solution Market Size (2020-2031)
8.2 Asia-Pacific Sterile Intravenous (IV) Solution Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2020-2025)
8.4 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sterile Intravenous (IV) Solution Market Size (2020-2031)
9.2 Latin America Sterile Intravenous (IV) Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sterile Intravenous (IV) Solution Market Size by Country (2020-2025)
9.4 Latin America Sterile Intravenous (IV) Solution Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sterile Intravenous (IV) Solution Market Size (2020-2031)
10.2 Middle East & Africa Sterile Intravenous (IV) Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2020-2025)
10.4 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 B. Braun Medical Inc.
11.1.1 B. Braun Medical Inc. Company Details
11.1.2 B. Braun Medical Inc. Business Overview
11.1.3 B. Braun Medical Inc. Sterile Intravenous (IV) Solution Introduction
11.1.4 B. Braun Medical Inc. Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.1.5 B. Braun Medical Inc. Recent Development
11.2 Technoflex
11.2.1 Technoflex Company Details
11.2.2 Technoflex Business Overview
11.2.3 Technoflex Sterile Intravenous (IV) Solution Introduction
11.2.4 Technoflex Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.2.5 Technoflex Recent Development
11.3 Baxter International
11.3.1 Baxter International Company Details
11.3.2 Baxter International Business Overview
11.3.3 Baxter International Sterile Intravenous (IV) Solution Introduction
11.3.4 Baxter International Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.3.5 Baxter International Recent Development
11.4 ICU Medical, Inc
11.4.1 ICU Medical, Inc Company Details
11.4.2 ICU Medical, Inc Business Overview
11.4.3 ICU Medical, Inc Sterile Intravenous (IV) Solution Introduction
11.4.4 ICU Medical, Inc Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.4.5 ICU Medical, Inc Recent Development
11.5 Mckesson
11.5.1 Mckesson Company Details
11.5.2 Mckesson Business Overview
11.5.3 Mckesson Sterile Intravenous (IV) Solution Introduction
11.5.4 Mckesson Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.5.5 Mckesson Recent Development
11.6 Amsino
11.6.1 Amsino Company Details
11.6.2 Amsino Business Overview
11.6.3 Amsino Sterile Intravenous (IV) Solution Introduction
11.6.4 Amsino Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.6.5 Amsino Recent Development
11.7 Wallcur
11.7.1 Wallcur Company Details
11.7.2 Wallcur Business Overview
11.7.3 Wallcur Sterile Intravenous (IV) Solution Introduction
11.7.4 Wallcur Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.7.5 Wallcur Recent Development
11.8 Hebei Guangren Pharmaceutical Technology
11.8.1 Hebei Guangren Pharmaceutical Technology Company Details
11.8.2 Hebei Guangren Pharmaceutical Technology Business Overview
11.8.3 Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Introduction
11.8.4 Hebei Guangren Pharmaceutical Technology Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.8.5 Hebei Guangren Pharmaceutical Technology Recent Development
11.9 Jiangsu Hengfengqiang Biotechnology
11.9.1 Jiangsu Hengfengqiang Biotechnology Company Details
11.9.2 Jiangsu Hengfengqiang Biotechnology Business Overview
11.9.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Introduction
11.9.4 Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.9.5 Jiangsu Hengfengqiang Biotechnology Recent Development
11.10 Hospira
11.10.1 Hospira Company Details
11.10.2 Hospira Business Overview
11.10.3 Hospira Sterile Intravenous (IV) Solution Introduction
11.10.4 Hospira Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.10.5 Hospira Recent Development
11.11 Jiangsu Hengfengqiang Biotechnology
11.11.1 Jiangsu Hengfengqiang Biotechnology Company Details
11.11.2 Jiangsu Hengfengqiang Biotechnology Business Overview
11.11.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Introduction
11.11.4 Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.11.5 Jiangsu Hengfengqiang Biotechnology Recent Development
11.12 Hospira
11.12.1 Hospira Company Details
11.12.2 Hospira Business Overview
11.12.3 Hospira Sterile Intravenous (IV) Solution Introduction
11.12.4 Hospira Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.12.5 Hospira Recent Development
11.13 Xi'an Libang Alliance Enterprise Management
11.13.1 Xi'an Libang Alliance Enterprise Management Company Details
11.13.2 Xi'an Libang Alliance Enterprise Management Business Overview
11.13.3 Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Introduction
11.13.4 Xi'an Libang Alliance Enterprise Management Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.13.5 Xi'an Libang Alliance Enterprise Management Recent Development
11.14 Livzon Group
11.14.1 Livzon Group Company Details
11.14.2 Livzon Group Business Overview
11.14.3 Livzon Group Sterile Intravenous (IV) Solution Introduction
11.14.4 Livzon Group Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.14.5 Livzon Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Crystalloids
1.2.3 Colloids
1.2.4 Others
1.3 Market by Application
1.3.1 Global Sterile Intravenous (IV) Solution Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medications
1.3.3 NutritionNutrition
1.3.4 Blood-based Products
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sterile Intravenous (IV) Solution Market Perspective (2020-2031)
2.2 Global Sterile Intravenous (IV) Solution Growth Trends by Region
2.2.1 Global Sterile Intravenous (IV) Solution Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sterile Intravenous (IV) Solution Historic Market Size by Region (2020-2025)
2.2.3 Sterile Intravenous (IV) Solution Forecasted Market Size by Region (2026-2031)
2.3 Sterile Intravenous (IV) Solution Market Dynamics
2.3.1 Sterile Intravenous (IV) Solution Industry Trends
2.3.2 Sterile Intravenous (IV) Solution Market Drivers
2.3.3 Sterile Intravenous (IV) Solution Market Challenges
2.3.4 Sterile Intravenous (IV) Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sterile Intravenous (IV) Solution Players by Revenue
3.1.1 Global Top Sterile Intravenous (IV) Solution Players by Revenue (2020-2025)
3.1.2 Global Sterile Intravenous (IV) Solution Revenue Market Share by Players (2020-2025)
3.2 Global Sterile Intravenous (IV) Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sterile Intravenous (IV) Solution Revenue
3.4 Global Sterile Intravenous (IV) Solution Market Concentration Ratio
3.4.1 Global Sterile Intravenous (IV) Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sterile Intravenous (IV) Solution Revenue in 2024
3.5 Global Key Players of Sterile Intravenous (IV) Solution Head office and Area Served
3.6 Global Key Players of Sterile Intravenous (IV) Solution, Product and Application
3.7 Global Key Players of Sterile Intravenous (IV) Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sterile Intravenous (IV) Solution Breakdown Data by Type
4.1 Global Sterile Intravenous (IV) Solution Historic Market Size by Type (2020-2025)
4.2 Global Sterile Intravenous (IV) Solution Forecasted Market Size by Type (2026-2031)
5 Sterile Intravenous (IV) Solution Breakdown Data by Application
5.1 Global Sterile Intravenous (IV) Solution Historic Market Size by Application (2020-2025)
5.2 Global Sterile Intravenous (IV) Solution Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sterile Intravenous (IV) Solution Market Size (2020-2031)
6.2 North America Sterile Intravenous (IV) Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sterile Intravenous (IV) Solution Market Size by Country (2020-2025)
6.4 North America Sterile Intravenous (IV) Solution Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sterile Intravenous (IV) Solution Market Size (2020-2031)
7.2 Europe Sterile Intravenous (IV) Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sterile Intravenous (IV) Solution Market Size by Country (2020-2025)
7.4 Europe Sterile Intravenous (IV) Solution Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sterile Intravenous (IV) Solution Market Size (2020-2031)
8.2 Asia-Pacific Sterile Intravenous (IV) Solution Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2020-2025)
8.4 Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sterile Intravenous (IV) Solution Market Size (2020-2031)
9.2 Latin America Sterile Intravenous (IV) Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sterile Intravenous (IV) Solution Market Size by Country (2020-2025)
9.4 Latin America Sterile Intravenous (IV) Solution Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sterile Intravenous (IV) Solution Market Size (2020-2031)
10.2 Middle East & Africa Sterile Intravenous (IV) Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2020-2025)
10.4 Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 B. Braun Medical Inc.
11.1.1 B. Braun Medical Inc. Company Details
11.1.2 B. Braun Medical Inc. Business Overview
11.1.3 B. Braun Medical Inc. Sterile Intravenous (IV) Solution Introduction
11.1.4 B. Braun Medical Inc. Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.1.5 B. Braun Medical Inc. Recent Development
11.2 Technoflex
11.2.1 Technoflex Company Details
11.2.2 Technoflex Business Overview
11.2.3 Technoflex Sterile Intravenous (IV) Solution Introduction
11.2.4 Technoflex Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.2.5 Technoflex Recent Development
11.3 Baxter International
11.3.1 Baxter International Company Details
11.3.2 Baxter International Business Overview
11.3.3 Baxter International Sterile Intravenous (IV) Solution Introduction
11.3.4 Baxter International Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.3.5 Baxter International Recent Development
11.4 ICU Medical, Inc
11.4.1 ICU Medical, Inc Company Details
11.4.2 ICU Medical, Inc Business Overview
11.4.3 ICU Medical, Inc Sterile Intravenous (IV) Solution Introduction
11.4.4 ICU Medical, Inc Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.4.5 ICU Medical, Inc Recent Development
11.5 Mckesson
11.5.1 Mckesson Company Details
11.5.2 Mckesson Business Overview
11.5.3 Mckesson Sterile Intravenous (IV) Solution Introduction
11.5.4 Mckesson Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.5.5 Mckesson Recent Development
11.6 Amsino
11.6.1 Amsino Company Details
11.6.2 Amsino Business Overview
11.6.3 Amsino Sterile Intravenous (IV) Solution Introduction
11.6.4 Amsino Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.6.5 Amsino Recent Development
11.7 Wallcur
11.7.1 Wallcur Company Details
11.7.2 Wallcur Business Overview
11.7.3 Wallcur Sterile Intravenous (IV) Solution Introduction
11.7.4 Wallcur Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.7.5 Wallcur Recent Development
11.8 Hebei Guangren Pharmaceutical Technology
11.8.1 Hebei Guangren Pharmaceutical Technology Company Details
11.8.2 Hebei Guangren Pharmaceutical Technology Business Overview
11.8.3 Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Introduction
11.8.4 Hebei Guangren Pharmaceutical Technology Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.8.5 Hebei Guangren Pharmaceutical Technology Recent Development
11.9 Jiangsu Hengfengqiang Biotechnology
11.9.1 Jiangsu Hengfengqiang Biotechnology Company Details
11.9.2 Jiangsu Hengfengqiang Biotechnology Business Overview
11.9.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Introduction
11.9.4 Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.9.5 Jiangsu Hengfengqiang Biotechnology Recent Development
11.10 Hospira
11.10.1 Hospira Company Details
11.10.2 Hospira Business Overview
11.10.3 Hospira Sterile Intravenous (IV) Solution Introduction
11.10.4 Hospira Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.10.5 Hospira Recent Development
11.11 Jiangsu Hengfengqiang Biotechnology
11.11.1 Jiangsu Hengfengqiang Biotechnology Company Details
11.11.2 Jiangsu Hengfengqiang Biotechnology Business Overview
11.11.3 Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Introduction
11.11.4 Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.11.5 Jiangsu Hengfengqiang Biotechnology Recent Development
11.12 Hospira
11.12.1 Hospira Company Details
11.12.2 Hospira Business Overview
11.12.3 Hospira Sterile Intravenous (IV) Solution Introduction
11.12.4 Hospira Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.12.5 Hospira Recent Development
11.13 Xi'an Libang Alliance Enterprise Management
11.13.1 Xi'an Libang Alliance Enterprise Management Company Details
11.13.2 Xi'an Libang Alliance Enterprise Management Business Overview
11.13.3 Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Introduction
11.13.4 Xi'an Libang Alliance Enterprise Management Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.13.5 Xi'an Libang Alliance Enterprise Management Recent Development
11.14 Livzon Group
11.14.1 Livzon Group Company Details
11.14.2 Livzon Group Business Overview
11.14.3 Livzon Group Sterile Intravenous (IV) Solution Introduction
11.14.4 Livzon Group Revenue in Sterile Intravenous (IV) Solution Business (2020-2025)
11.14.5 Livzon Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Crystalloids
Table 3. Key Players of Colloids
Table 4. Key Players of Others
Table 5. Global Sterile Intravenous (IV) Solution Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sterile Intravenous (IV) Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Sterile Intravenous (IV) Solution Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Sterile Intravenous (IV) Solution Market Share by Region (2020-2025)
Table 9. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Sterile Intravenous (IV) Solution Market Share by Region (2026-2031)
Table 11. Sterile Intravenous (IV) Solution Market Trends
Table 12. Sterile Intravenous (IV) Solution Market Drivers
Table 13. Sterile Intravenous (IV) Solution Market Challenges
Table 14. Sterile Intravenous (IV) Solution Market Restraints
Table 15. Global Sterile Intravenous (IV) Solution Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Sterile Intravenous (IV) Solution Market Share by Players (2020-2025)
Table 17. Global Top Sterile Intravenous (IV) Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Intravenous (IV) Solution as of 2024)
Table 18. Ranking of Global Top Sterile Intravenous (IV) Solution Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Sterile Intravenous (IV) Solution Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Sterile Intravenous (IV) Solution, Headquarters and Area Served
Table 21. Global Key Players of Sterile Intravenous (IV) Solution, Product and Application
Table 22. Global Key Players of Sterile Intravenous (IV) Solution, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sterile Intravenous (IV) Solution Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Sterile Intravenous (IV) Solution Revenue Market Share by Type (2020-2025)
Table 26. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Sterile Intravenous (IV) Solution Revenue Market Share by Type (2026-2031)
Table 28. Global Sterile Intravenous (IV) Solution Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Sterile Intravenous (IV) Solution Revenue Market Share by Application (2020-2025)
Table 30. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Sterile Intravenous (IV) Solution Revenue Market Share by Application (2026-2031)
Table 32. North America Sterile Intravenous (IV) Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Sterile Intravenous (IV) Solution Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Sterile Intravenous (IV) Solution Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Sterile Intravenous (IV) Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Sterile Intravenous (IV) Solution Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Sterile Intravenous (IV) Solution Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Sterile Intravenous (IV) Solution Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Sterile Intravenous (IV) Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Sterile Intravenous (IV) Solution Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Sterile Intravenous (IV) Solution Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Sterile Intravenous (IV) Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2026-2031) & (US$ Million)
Table 47. B. Braun Medical Inc. Company Details
Table 48. B. Braun Medical Inc. Business Overview
Table 49. B. Braun Medical Inc. Sterile Intravenous (IV) Solution Product
Table 50. B. Braun Medical Inc. Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 51. B. Braun Medical Inc. Recent Development
Table 52. Technoflex Company Details
Table 53. Technoflex Business Overview
Table 54. Technoflex Sterile Intravenous (IV) Solution Product
Table 55. Technoflex Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 56. Technoflex Recent Development
Table 57. Baxter International Company Details
Table 58. Baxter International Business Overview
Table 59. Baxter International Sterile Intravenous (IV) Solution Product
Table 60. Baxter International Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 61. Baxter International Recent Development
Table 62. ICU Medical, Inc Company Details
Table 63. ICU Medical, Inc Business Overview
Table 64. ICU Medical, Inc Sterile Intravenous (IV) Solution Product
Table 65. ICU Medical, Inc Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 66. ICU Medical, Inc Recent Development
Table 67. Mckesson Company Details
Table 68. Mckesson Business Overview
Table 69. Mckesson Sterile Intravenous (IV) Solution Product
Table 70. Mckesson Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 71. Mckesson Recent Development
Table 72. Amsino Company Details
Table 73. Amsino Business Overview
Table 74. Amsino Sterile Intravenous (IV) Solution Product
Table 75. Amsino Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 76. Amsino Recent Development
Table 77. Wallcur Company Details
Table 78. Wallcur Business Overview
Table 79. Wallcur Sterile Intravenous (IV) Solution Product
Table 80. Wallcur Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 81. Wallcur Recent Development
Table 82. Hebei Guangren Pharmaceutical Technology Company Details
Table 83. Hebei Guangren Pharmaceutical Technology Business Overview
Table 84. Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Product
Table 85. Hebei Guangren Pharmaceutical Technology Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 86. Hebei Guangren Pharmaceutical Technology Recent Development
Table 87. Jiangsu Hengfengqiang Biotechnology Company Details
Table 88. Jiangsu Hengfengqiang Biotechnology Business Overview
Table 89. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product
Table 90. Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 91. Jiangsu Hengfengqiang Biotechnology Recent Development
Table 92. Hospira Company Details
Table 93. Hospira Business Overview
Table 94. Hospira Sterile Intravenous (IV) Solution Product
Table 95. Hospira Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 96. Hospira Recent Development
Table 97. Jiangsu Hengfengqiang Biotechnology Company Details
Table 98. Jiangsu Hengfengqiang Biotechnology Business Overview
Table 99. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product
Table 100. Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 101. Jiangsu Hengfengqiang Biotechnology Recent Development
Table 102. Hospira Company Details
Table 103. Hospira Business Overview
Table 104. Hospira Sterile Intravenous (IV) Solution Product
Table 105. Hospira Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 106. Hospira Recent Development
Table 107. Xi'an Libang Alliance Enterprise Management Company Details
Table 108. Xi'an Libang Alliance Enterprise Management Business Overview
Table 109. Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Product
Table 110. Xi'an Libang Alliance Enterprise Management Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 111. Xi'an Libang Alliance Enterprise Management Recent Development
Table 112. Livzon Group Company Details
Table 113. Livzon Group Business Overview
Table 114. Livzon Group Sterile Intravenous (IV) Solution Product
Table 115. Livzon Group Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 116. Livzon Group Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. Sterile Intravenous (IV) Solution Picture
Figure 2. Global Sterile Intravenous (IV) Solution Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sterile Intravenous (IV) Solution Market Share by Type: 2024 VS 2031
Figure 4. Crystalloids Features
Figure 5. Colloids Features
Figure 6. Others Features
Figure 7. Global Sterile Intravenous (IV) Solution Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Sterile Intravenous (IV) Solution Market Share by Application: 2024 VS 2031
Figure 9. Medications Case Studies
Figure 10. NutritionNutrition Case Studies
Figure 11. Blood-based Products Case Studies
Figure 12. Others Case Studies
Figure 13. Sterile Intravenous (IV) Solution Report Years Considered
Figure 14. Global Sterile Intravenous (IV) Solution Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Sterile Intravenous (IV) Solution Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Sterile Intravenous (IV) Solution Market Share by Region: 2024 VS 2031
Figure 17. Global Sterile Intravenous (IV) Solution Market Share by Players in 2024
Figure 18. Global Top Sterile Intravenous (IV) Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Intravenous (IV) Solution as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Sterile Intravenous (IV) Solution Revenue in 2024
Figure 20. North America Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Sterile Intravenous (IV) Solution Market Share by Country (2020-2031)
Figure 22. United States Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Sterile Intravenous (IV) Solution Market Share by Country (2020-2031)
Figure 26. Germany Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Sterile Intravenous (IV) Solution Market Share by Region (2020-2031)
Figure 34. China Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Sterile Intravenous (IV) Solution Market Share by Country (2020-2031)
Figure 42. Mexico Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Sterile Intravenous (IV) Solution Market Share by Country (2020-2031)
Figure 46. Turkey Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. B. Braun Medical Inc. Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 50. Technoflex Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 51. Baxter International Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 52. ICU Medical, Inc Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 53. Mckesson Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 54. Amsino Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 55. Wallcur Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 56. Hebei Guangren Pharmaceutical Technology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 57. Jiangsu Hengfengqiang Biotechnology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 58. Hospira Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 59. Jiangsu Hengfengqiang Biotechnology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 60. Hospira Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 61. Xi'an Libang Alliance Enterprise Management Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 62. Livzon Group Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Sterile Intravenous (IV) Solution Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Crystalloids
Table 3. Key Players of Colloids
Table 4. Key Players of Others
Table 5. Global Sterile Intravenous (IV) Solution Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Sterile Intravenous (IV) Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Sterile Intravenous (IV) Solution Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Sterile Intravenous (IV) Solution Market Share by Region (2020-2025)
Table 9. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Sterile Intravenous (IV) Solution Market Share by Region (2026-2031)
Table 11. Sterile Intravenous (IV) Solution Market Trends
Table 12. Sterile Intravenous (IV) Solution Market Drivers
Table 13. Sterile Intravenous (IV) Solution Market Challenges
Table 14. Sterile Intravenous (IV) Solution Market Restraints
Table 15. Global Sterile Intravenous (IV) Solution Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Sterile Intravenous (IV) Solution Market Share by Players (2020-2025)
Table 17. Global Top Sterile Intravenous (IV) Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Intravenous (IV) Solution as of 2024)
Table 18. Ranking of Global Top Sterile Intravenous (IV) Solution Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Sterile Intravenous (IV) Solution Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Sterile Intravenous (IV) Solution, Headquarters and Area Served
Table 21. Global Key Players of Sterile Intravenous (IV) Solution, Product and Application
Table 22. Global Key Players of Sterile Intravenous (IV) Solution, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Sterile Intravenous (IV) Solution Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Sterile Intravenous (IV) Solution Revenue Market Share by Type (2020-2025)
Table 26. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Sterile Intravenous (IV) Solution Revenue Market Share by Type (2026-2031)
Table 28. Global Sterile Intravenous (IV) Solution Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Sterile Intravenous (IV) Solution Revenue Market Share by Application (2020-2025)
Table 30. Global Sterile Intravenous (IV) Solution Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Sterile Intravenous (IV) Solution Revenue Market Share by Application (2026-2031)
Table 32. North America Sterile Intravenous (IV) Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Sterile Intravenous (IV) Solution Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Sterile Intravenous (IV) Solution Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Sterile Intravenous (IV) Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Sterile Intravenous (IV) Solution Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Sterile Intravenous (IV) Solution Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Sterile Intravenous (IV) Solution Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Sterile Intravenous (IV) Solution Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Sterile Intravenous (IV) Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Sterile Intravenous (IV) Solution Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Sterile Intravenous (IV) Solution Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Sterile Intravenous (IV) Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Sterile Intravenous (IV) Solution Market Size by Country (2026-2031) & (US$ Million)
Table 47. B. Braun Medical Inc. Company Details
Table 48. B. Braun Medical Inc. Business Overview
Table 49. B. Braun Medical Inc. Sterile Intravenous (IV) Solution Product
Table 50. B. Braun Medical Inc. Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 51. B. Braun Medical Inc. Recent Development
Table 52. Technoflex Company Details
Table 53. Technoflex Business Overview
Table 54. Technoflex Sterile Intravenous (IV) Solution Product
Table 55. Technoflex Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 56. Technoflex Recent Development
Table 57. Baxter International Company Details
Table 58. Baxter International Business Overview
Table 59. Baxter International Sterile Intravenous (IV) Solution Product
Table 60. Baxter International Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 61. Baxter International Recent Development
Table 62. ICU Medical, Inc Company Details
Table 63. ICU Medical, Inc Business Overview
Table 64. ICU Medical, Inc Sterile Intravenous (IV) Solution Product
Table 65. ICU Medical, Inc Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 66. ICU Medical, Inc Recent Development
Table 67. Mckesson Company Details
Table 68. Mckesson Business Overview
Table 69. Mckesson Sterile Intravenous (IV) Solution Product
Table 70. Mckesson Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 71. Mckesson Recent Development
Table 72. Amsino Company Details
Table 73. Amsino Business Overview
Table 74. Amsino Sterile Intravenous (IV) Solution Product
Table 75. Amsino Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 76. Amsino Recent Development
Table 77. Wallcur Company Details
Table 78. Wallcur Business Overview
Table 79. Wallcur Sterile Intravenous (IV) Solution Product
Table 80. Wallcur Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 81. Wallcur Recent Development
Table 82. Hebei Guangren Pharmaceutical Technology Company Details
Table 83. Hebei Guangren Pharmaceutical Technology Business Overview
Table 84. Hebei Guangren Pharmaceutical Technology Sterile Intravenous (IV) Solution Product
Table 85. Hebei Guangren Pharmaceutical Technology Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 86. Hebei Guangren Pharmaceutical Technology Recent Development
Table 87. Jiangsu Hengfengqiang Biotechnology Company Details
Table 88. Jiangsu Hengfengqiang Biotechnology Business Overview
Table 89. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product
Table 90. Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 91. Jiangsu Hengfengqiang Biotechnology Recent Development
Table 92. Hospira Company Details
Table 93. Hospira Business Overview
Table 94. Hospira Sterile Intravenous (IV) Solution Product
Table 95. Hospira Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 96. Hospira Recent Development
Table 97. Jiangsu Hengfengqiang Biotechnology Company Details
Table 98. Jiangsu Hengfengqiang Biotechnology Business Overview
Table 99. Jiangsu Hengfengqiang Biotechnology Sterile Intravenous (IV) Solution Product
Table 100. Jiangsu Hengfengqiang Biotechnology Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 101. Jiangsu Hengfengqiang Biotechnology Recent Development
Table 102. Hospira Company Details
Table 103. Hospira Business Overview
Table 104. Hospira Sterile Intravenous (IV) Solution Product
Table 105. Hospira Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 106. Hospira Recent Development
Table 107. Xi'an Libang Alliance Enterprise Management Company Details
Table 108. Xi'an Libang Alliance Enterprise Management Business Overview
Table 109. Xi'an Libang Alliance Enterprise Management Sterile Intravenous (IV) Solution Product
Table 110. Xi'an Libang Alliance Enterprise Management Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 111. Xi'an Libang Alliance Enterprise Management Recent Development
Table 112. Livzon Group Company Details
Table 113. Livzon Group Business Overview
Table 114. Livzon Group Sterile Intravenous (IV) Solution Product
Table 115. Livzon Group Revenue in Sterile Intravenous (IV) Solution Business (2020-2025) & (US$ Million)
Table 116. Livzon Group Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
Table 120. Authors List of This Report
List of Figures
Figure 1. Sterile Intravenous (IV) Solution Picture
Figure 2. Global Sterile Intravenous (IV) Solution Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Sterile Intravenous (IV) Solution Market Share by Type: 2024 VS 2031
Figure 4. Crystalloids Features
Figure 5. Colloids Features
Figure 6. Others Features
Figure 7. Global Sterile Intravenous (IV) Solution Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Sterile Intravenous (IV) Solution Market Share by Application: 2024 VS 2031
Figure 9. Medications Case Studies
Figure 10. NutritionNutrition Case Studies
Figure 11. Blood-based Products Case Studies
Figure 12. Others Case Studies
Figure 13. Sterile Intravenous (IV) Solution Report Years Considered
Figure 14. Global Sterile Intravenous (IV) Solution Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Sterile Intravenous (IV) Solution Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Sterile Intravenous (IV) Solution Market Share by Region: 2024 VS 2031
Figure 17. Global Sterile Intravenous (IV) Solution Market Share by Players in 2024
Figure 18. Global Top Sterile Intravenous (IV) Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Intravenous (IV) Solution as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Sterile Intravenous (IV) Solution Revenue in 2024
Figure 20. North America Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Sterile Intravenous (IV) Solution Market Share by Country (2020-2031)
Figure 22. United States Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Sterile Intravenous (IV) Solution Market Share by Country (2020-2031)
Figure 26. Germany Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Sterile Intravenous (IV) Solution Market Share by Region (2020-2031)
Figure 34. China Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Sterile Intravenous (IV) Solution Market Share by Country (2020-2031)
Figure 42. Mexico Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Sterile Intravenous (IV) Solution Market Share by Country (2020-2031)
Figure 46. Turkey Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Sterile Intravenous (IV) Solution Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. B. Braun Medical Inc. Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 50. Technoflex Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 51. Baxter International Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 52. ICU Medical, Inc Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 53. Mckesson Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 54. Amsino Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 55. Wallcur Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 56. Hebei Guangren Pharmaceutical Technology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 57. Jiangsu Hengfengqiang Biotechnology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 58. Hospira Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 59. Jiangsu Hengfengqiang Biotechnology Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 60. Hospira Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 61. Xi'an Libang Alliance Enterprise Management Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 62. Livzon Group Revenue Growth Rate in Sterile Intravenous (IV) Solution Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232